Scynexis (SCYX) Other Non-Current Liabilities (2013 - 2026)

Scynexis (SCYX) posted Other Non-Current Liabilities of $18.9 million for Q1 2026, up 759.09% on a QoQ basis from $2.2 million in Q4 2025, and up 270.59% year-over-year from $5.1 million in Q1 2025.

Scynexis (SCYX) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends

Scynexis' Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $18.9 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 270.59% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.9 million (up 270.59% YoY) and the FY2025 annual result came in at $2.2 million, down 72.5% from the prior year.
  • Other Non-Current Liabilities was $18.9 million for Q1 2026 at Scynexis, up from $2.2 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $40.3 million in Q1 2023 and bottomed at $2.2 million in Q4 2025.
  • A 5-year average of $15.2 million and a median of $12.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 5557.86% — and 2025, when it tumbled 83.89%.
  • Scynexis' Other Non-Current Liabilities stood at $18.6 million in 2022, then gained by 16.56% to $21.7 million in 2023, then sank by 63.1% to $8.0 million in 2024, then slumped by 72.5% to $2.2 million in 2025, then soared by 759.09% to $18.9 million in 2026.
  • Business Quant data shows SCYX's Other Non-Current Liabilities at $18.9 million in Q1 2026, $2.2 million in Q4 2025, and $3.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Scynexis 21.55 Mn -15.20 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 18.90 Mn
Dec 31, 2025 2.20 Mn
Sep 30, 2025 3.54 Mn
Jun 30, 2025 2.90 Mn
Mar 31, 2025 5.10 Mn
Dec 31, 2024 8.00 Mn
Sep 30, 2024 11.21 Mn
Jun 30, 2024 18.00 Mn
Mar 31, 2024 12.20 Mn
Dec 31, 2023 21.68 Mn
Sep 30, 2023 24.60 Mn
Jun 30, 2023 30.09 Mn
Mar 31, 2023 40.32 Mn
Dec 31, 2022 18.60 Mn
Sep 30, 2022 27.73 Mn
Jun 30, 2022 5.06 Mn
Mar 31, 2022 7.92 Mn
Dec 31, 2021 3.35 Mn
Sep 30, 2021 2.10 Mn
Jun 30, 2021 24.45 Mn